US Senate debates AI regulation as imaging AI firms see funding and labs drive adoption, amid aging IT causing security concerns.
Key Details
- 1Senate Republicans are split over federal vs. state control of AI regulation, with some pushing a 10-year federal moratorium.
- 295% of healthcare IT leaders report using outdated systems; 59% face tech downtime and 45% cite security vulnerabilities.
- 3Pathology labs are adopting AI, with 25% citing improved diagnosis accuracy and >30% valuing efficiency gains.
- 4Recent radiology/AI start-ups raised $101M (referral simplification) and $32M (imaging AI firm HOPPR, led by notable radiologists).
- 5AI-driven ransomware threats are rising, prompting calls for improved healthcare IT security.
- 6AI is predicted to impact healthcare employment less than other sectors due to elasticity of healthcare demand.
Why It Matters
Major regulatory, security, and infrastructure shifts will directly impact adoption, safety, and market growth for imaging AI. The influx of funding and recognition among labs signals ongoing acceleration of radiology and pathology AI solutions, even as systemic IT weaknesses pose ongoing risks.
Source
AI in Healthcare
Related News
•AuntMinnie
Vast Majority of FDA-Cleared Radiology AI Devices Lack Outcome Trials
Only 0.3% of FDA-cleared radiology AI devices have registered trials on patient outcomes, raising concerns about evidence standards.
•Radiology Business
Radiology Partners Urges FDA for Clarity on Imaging AI Regulations
Radiology Partners and Mosaic Clinical Technologies petition the FDA for clearer regulatory guidelines on imaging AI vision-language models.
•Radiology Business
FDA Solicits Public Input on Regulating Generative AI in Medical Devices
The FDA is seeking public feedback on how to regulate generative AI in medical devices, recognizing both its promise and risks.